Resource Library

This resource library includes tools and resources such as reports, white papers, news, patient information and downloadable materials related to the biosimilars, specific to multiple sclerosis (MS) and select anti-inflammatory/rheumatological biosimilars. Additionally, it includes key documents needed for your practice such as Medication Use Evaluation (MUE), P&T Committee articles, and checklists to help onboard new and emerging biosimilar products. Simply by clicking on the areas you wish to explore and access these valuable tools and resources.

27 Results

Accelerating Biosimilar Adoption: Conversation with the Experts

Topics: Implementation

New and upcoming biosimilar launches

Topics: Implementation

Biosimilars and Biologics: Implementation and Monitoring in a Healthcare Setting

Topics: Implementation

Approved Risk Evaluation and Mitigation Strategies (REMS)

Topics: Implementation, Multiple Sclerosis

Prescribing Biosimilar and Interchangeable Biosimilar Products

Topics: Implementation

Curriculum Materials for Health Care Degree Programs – Biosimilars

Topics: Implementation

Overview of Biosimilar Products

Topics: Implementation

Biosimilars: What Patients Need to Know

Topics: Implementation

Real-world evidence of a successful biosimilar adoption program

Topics: Implementation

Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care

Topics: Implementation

Biosimilars Are Here: A Hospital Pharmacist’s Guide to Educating Health Care Professionals on Biosimilars

Topics: Implementation

Biosimilar Basics for Patients

Topics: Implementation

Biosimilar medicines uptake: The role of the clinical pharmacist

Topics: Implementation

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

Topics: Implementation, P&T Committee

Biosimilars – Providing Affordable, Accessible Care for Patients

Topics: Economics, Implementation

Switching from Biologic to Biosimilar Products: Insight from an Integrated Health Care System

Topics: Implementation

Process and Clinical Outcomes of a Biosimilar Adoption Program with Infliximab-Dyyb

Topics: Implementation

Implementation Strategies of Biosimilars in Healthcare Systems: The Path Forward

Topics: Implementation

Overcoming barriers to biosimilar adoption: real-world perspectives from a national payer and provider initiative

Topics: Implementation, Payers

Best Practices in Formulary Management Unique Strategies for Biosimilar Adoption

Topics: Implementation

Page 1 of 2

Resource Library

Resource type

Topic

Search for keywords in resource title

Accelerating Biosimilar Adoption: Conversation with the Experts

New and upcoming biosimilar launches

Biosimilars and Biologics: Implementation and Monitoring in a Healthcare Setting

Approved Risk Evaluation and Mitigation Strategies (REMS)

Prescribing Biosimilar and Interchangeable Biosimilar Products

Curriculum Materials for Health Care Degree Programs – Biosimilars

Overview of Biosimilar Products

Biosimilars: What Patients Need to Know

Real-world evidence of a successful biosimilar adoption program

Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care

Biosimilars Are Here: A Hospital Pharmacist’s Guide to Educating Health Care Professionals on Biosimilars

Biosimilar Basics for Patients

Biosimilar medicines uptake: The role of the clinical pharmacist

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

Biosimilars – Providing Affordable, Accessible Care for Patients

Switching from Biologic to Biosimilar Products: Insight from an Integrated Health Care System

Process and Clinical Outcomes of a Biosimilar Adoption Program with Infliximab-Dyyb

Implementation Strategies of Biosimilars in Healthcare Systems: The Path Forward

Overcoming barriers to biosimilar adoption: real-world perspectives from a national payer and provider initiative

Best Practices in Formulary Management Unique Strategies for Biosimilar Adoption